HIV investigational vaccine protected monkeys from HIV-like virus: Duke research
by Press Release from Outbreak News Today on (#2S9CE)
Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke-led research team used a more-is-better approach in monkeys that appeared to improve vaccine protection from an HIV-like virus. Adding three more targets to the investigational vaccine, for a total of five, ["]
The post HIV investigational vaccine protected monkeys from HIV-like virus: Duke research appeared first on Outbreak News Today.